ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.34B
1-Year Est. Return 288.83%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+288.83%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.34B
AUM Growth
+$327M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
284
New
Increased
Reduced
Closed

Top Buys

1
+$31.8M
2
+$14.2M
3
+$12.6M
4
TERN icon
Terns Pharmaceuticals
TERN
+$12.3M
5
ABUS icon
Arbutus Biopharma
ABUS
+$11.3M

Top Sells

1
+$94.2M
2
+$31.1M
3
+$15.5M
4
MTSR
Metsera Inc
MTSR
+$7.98M
5
IVVD icon
Invivyd
IVVD
+$7.22M

Sector Composition

1 Healthcare 90.32%
2 Financials 1.75%
3 Real Estate 0.13%
4 Communication Services 0.08%
5 Consumer Discretionary 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DHR icon
51
Danaher
DHR
$146B
$5.86M 0.44%
+25,600
CLYM
52
Climb Bio
CLYM
$482M
$5.73M 0.43%
1,432,475
+1,298,945
QURE icon
53
uniQure
QURE
$654M
$5.63M 0.42%
235,155
+101,839
RYTM icon
54
Rhythm Pharmaceuticals
RYTM
$6.34B
$5.5M 0.41%
51,349
+1,778
OACCU
55
Oaktree Acquisition Corp III Life Sciences Unit
OACCU
$5.49M 0.41%
516,482
ASND icon
56
Ascendis Pharma
ASND
$14.9B
$5.4M 0.4%
25,314
-11,031
AGIO icon
57
Agios Pharmaceuticals
AGIO
$1.71B
$5.12M 0.38%
188,000
+151,000
SPRB
58
Spruce Biosciences, Inc. Common Stock
SPRB
$58M
$5.05M 0.38%
+58,000
MLYS icon
59
Mineralys Therapeutics
MLYS
$2.32B
$4.94M 0.37%
136,231
+57,993
KRYS icon
60
Krystal Biotech
KRYS
$7.57B
$4.93M 0.37%
20,014
+1,491
PALI icon
61
Palisade Bio
PALI
$270M
$4.71M 0.35%
+2,004,845
SPRY icon
62
ARS Pharmaceuticals
SPRY
$906M
$4.31M 0.32%
369,569
+310,339
BIIB icon
63
Biogen
BIIB
$27.6B
$4.28M 0.32%
24,300
+6,300
NAMS icon
64
NewAmsterdam Pharma
NAMS
$3.77B
$4.16M 0.31%
118,623
+4,264
AEXA
65
American Exceptionalism Acquisition Corp
AEXA
$547M
$4.07M 0.3%
357,539
+307,539
ARWR icon
66
Arrowhead Research
ARWR
$9.01B
$3.86M 0.29%
58,200
+8,400
ATAI icon
67
AtaiBeckley Inc
ATAI
$1.34B
$3.74M 0.28%
913,242
CRVS icon
68
Corvus Pharmaceuticals
CRVS
$1.5B
$3.59M 0.27%
+465,875
JANX icon
69
Janux Therapeutics
JANX
$807M
$3.39M 0.25%
245,452
-105,580
GLUE icon
70
Monte Rosa Therapeutics
GLUE
$1.41B
$3.38M 0.25%
215,752
AVDL
71
DELISTED
Avadel Pharmaceuticals
AVDL
$3.24M 0.24%
+150,532
CTNM
72
Contineum Therapeutics
CTNM
$560M
$3.19M 0.24%
278,961
+201,000
EVMN
73
Evommune Inc
EVMN
$807M
$3.15M 0.24%
+184,062
SNY icon
74
Sanofi
SNY
$115B
$3.08M 0.23%
63,474
-10,738
SRRK icon
75
Scholar Rock
SRRK
$4.44B
$3.07M 0.23%
69,589
+49,502
1 2
3
4 5